- Home
- ORMP vs CBAT Comparison
ORMP vs CBAT Comparison
Compare ORMP & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- CBAT
- Stock Information
- Founded
- ORMP 2002
- CBAT 1999
- Country
- ORMP United States
- CBAT China
- Employees
- ORMP N/A
- CBAT N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- ORMP Health Care
- CBAT Miscellaneous
- Exchange
- ORMP Nasdaq
- CBAT Nasdaq
- Market Cap
- ORMP 90.2M
- CBAT 90.4M
- IPO Year
- ORMP N/A
- CBAT N/A
- Fundamental
- Price
- ORMP $2.32
- CBAT $0.88
- Analyst Decision
- ORMP Hold
- CBAT
- Analyst Count
- ORMP 1
- CBAT 0
- Target Price
- ORMP N/A
- CBAT N/A
- AVG Volume (30 Days)
- ORMP 96.9K
- CBAT 174.1K
- Earning Date
- ORMP 11-06-2025
- CBAT 11-11-2025
- Dividend Yield
- ORMP N/A
- CBAT N/A
- EPS Growth
- ORMP N/A
- CBAT N/A
- EPS
- ORMP N/A
- CBAT N/A
- Revenue
- ORMP $2,000,000.00
- CBAT $145,462,366.00
- Revenue This Year
- ORMP N/A
- CBAT N/A
- Revenue Next Year
- ORMP N/A
- CBAT $78.62
- P/E Ratio
- ORMP N/A
- CBAT N/A
- Revenue Growth
- ORMP N/A
- CBAT N/A
- 52 Week Low
- ORMP $1.82
- CBAT $0.57
- 52 Week High
- ORMP $3.09
- CBAT $1.30
- Technical
- Relative Strength Index (RSI)
- ORMP 59.64
- CBAT 35.46
- Support Level
- ORMP $2.17
- CBAT $0.88
- Resistance Level
- ORMP $2.45
- CBAT $0.94
- Average True Range (ATR)
- ORMP 0.07
- CBAT 0.04
- MACD
- ORMP 0.02
- CBAT -0.00
- Stochastic Oscillator
- ORMP 61.76
- CBAT 25.91
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.